Pulse Biosciences CS (PLSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 13,655 | 11,726 | 10,615 | 12,533 | 11,252 |
| Operating Income | -13,655 | -11,726 | -10,615 | -12,533 | -11,252 |
| Other Income | 975 | 343 | 478 | 600 | 686 |
| Pre-tax Income | -12,680 | -11,383 | -10,137 | -11,933 | -10,566 |
| Net Income Continuous | -12,680 | -11,383 | -10,137 | -11,933 | -10,566 |
| Net Income | $-12,680 | $-11,383 | $-10,137 | $-11,933 | $-10,566 |
| EPS Basic Total Ops | -0.21 | -0.20 | -0.18 | -0.18 | -0.19 |
| EPS Basic Continuous Ops | -0.21 | -0.20 | -0.18 | -0.19 | -0.19 |
| EPS Diluted Total Ops | -0.21 | -0.20 | -0.18 | -0.18 | -0.19 |
| EPS Diluted Continuous Ops | -0.21 | -0.20 | -0.18 | -0.19 | -0.19 |
| EPS Diluted Before Non-Recurring Items | -0.21 | N/A | -0.17 | N/A | N/A |
| EBITDA(a) | $-13,361 | $-11,428 | $-10,316 | $-12,229 | $-10,953 |